| P50 | author | Ping-Hsun Wu | Q51410244 |
| | Cheng-Chih Hsu | Q59453344 |
| | Su-Chu Lee | Q85022937 |
| | Yi-Chun Tsai | Q87647194 |
| P2093 | author name string | Shang-Jyh Hwang | |
| | Mei-Chuan Kuo | |
| | Yi-Wen Chiu | |
| | Yi-Ting Lin | |
| | Hsin-Bai Zou | |
| P2860 | cites work | The health benefits of dietary fiber: beyond the usual suspects of type 2 diabetes mellitus, cardiovascular disease and colon cancer | Q24306831 |
| | Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation | Q24316710 |
| | Intestinal Short Chain Fatty Acids and their Link with Diet and Human Health | Q26765857 |
| | Immunolocalization of BMP-6, a novel TGF-β-related cytokine, in normal and atherosclerotic smooth muscle cells | Q28292925 |
| | Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein | Q28304798 |
| | Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice | Q28508626 |
| | Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43 | Q28509150 |
| | Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells | Q29618126 |
| | Expansion of urease- and uricase-containing, indole- and p-cresol-forming and contraction of short-chain fatty acid-producing intestinal microbiota in ESRD. | Q33725646 |
| | Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides | Q34294058 |
| | Chronic kidney disease: global dimension and perspectives | Q34347984 |
| | The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism | Q34355154 |
| | Butyrate, an HDAC inhibitor, stimulates interplay between different posttranslational modifications of histone H3 and differently alters G1-specific cell cycle proteins in vascular smooth muscle cells | Q34384713 |
| | Targeting epigenetic DNA and histone modifications to treat kidney disease. | Q52657912 |
| | Altered microbiome in chronic kidney disease: systemic effects of gut-derived uremic toxins. | Q53703242 |
| | Supplementation of Short-Chain Fatty Acid, Sodium Propionate, in Patients on Maintenance-"Beneficial Effects on Inflammatory Parameters and Gut-Derived Uremic Toxins"-A Pilot Study (PLAN Study) | Q57064042 |
| | Gut Microbial Product Predicts Cardiovascular Risk in Chronic Kidney Disease Patients | Q57455386 |
| | Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils | Q63351671 |
| | High-performance liquid chromatographic analysis of serum short-chain fatty acids by direct derivatization | Q68538486 |
| | Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques | Q77350558 |
| | Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway | Q34681642 |
| | The role of short-chain fatty acids in health and disease. | Q35081696 |
| | Regulation of short-chain fatty acid production | Q35124759 |
| | Dietary restrictions in dialysis patients: is there anything left to eat? | Q35272314 |
| | Short-chain fatty acids induce pro-inflammatory cytokine production alone and in combination with toll-like receptor ligands | Q35784465 |
| | A reduction in the butyrate producing species Roseburia spp. and Faecalibacterium prausnitzii is associated with chronic kidney disease progression | Q36081100 |
| | Bone morphogenetic proteins in vascular calcification | Q36204129 |
| | The histone deacetylase inhibitor butyrate improves metabolism and reduces muscle atrophy during aging | Q36410021 |
| | Regulation of Vascular and Renal Function by Metabolite Receptors | Q36752430 |
| | Inhibition of bone morphogenetic protein signaling reduces vascular calcification and atherosclerosis | Q36921054 |
| | Functional expression of the olfactory signaling system in the kidney | Q37100981 |
| | Butyrate improves insulin sensitivity and increases energy expenditure in mice | Q37236322 |
| | Butyrate and other short-chain fatty acids as modulators of immunity: what relevance for health? | Q37786181 |
| | Regulation of inflammation by short chain fatty acids | Q37976701 |
| | Chronic kidney disease as a coronary artery disease risk equivalent | Q38075813 |
| | Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention | Q38111136 |
| | Transporters and receptors for short-chain fatty acids as the molecular link between colonic bacteria and the host | Q38131613 |
| | Modified Nutritional Recommendations to Improve Dietary Patterns and Outcomes in Hemodialysis Patients | Q38912173 |
| | Indoxyl Sulfate: A Novel Cardiovascular Risk Factor in Chronic Kidney Disease. | Q39125093 |
| | Short-chain fatty acids suppress lipopolysaccharide-induced production of nitric oxide and proinflammatory cytokines through inhibition of NF-κB pathway in RAW264.7 cells | Q39336547 |
| | The inflammatory cytokines TWEAK and TNFα reduce renal klotho expression through NFκB. | Q39515008 |
| | Use of a proximity extension assay proteomics chip to discover new biomarkers for human atherosclerosis | Q41555037 |
| | Short-chain free fatty acid receptors FFA2/GPR43 and FFA3/GPR41 as new potential therapeutic targets | Q41854852 |
| | GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon | Q42561059 |
| | Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids | Q42812646 |
| | Paracrine osteogenic signals via bone morphogenetic protein-2 accelerate the atherosclerotic intimal calcification in vivo | Q42961943 |
| | Anti-inflammatory effects of sodium butyrate on human monocytes: potent inhibition of IL-12 and up-regulation of IL-10 production | Q43508047 |
| | A novel antiinflammatory role for the short-chain fatty acids in human labor | Q45243622 |
| | Expression of short-chain fatty acid receptor GPR41 in the human colon. | Q45941513 |
| | The Chronic Kidney Disease - Colonic Axis | Q46415279 |
| | High-protein, reduced-carbohydrate weight-loss diets promote metabolite profiles likely to be detrimental to colonic health. | Q47387335 |
| | Short-chain fatty acids: a link between prebiotics and microbiota in chronic kidney disease. | Q47899492 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 12 | |
| P921 | main subject | hemodialysis patient | Q126109077 |
| P577 | publication date | 2019-12-12 | |
| P1433 | published in | Nutrients | Q7070485 |
| P1476 | title | Exploring the Benefit of 2-Methylbutyric Acid in Patients Undergoing Hemodialysis Using a Cardiovascular Proteomics Approach | |
| P478 | volume | 11 | |